Dentsply Sirona Appoints Donald Zurbay to Board of Directors

CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the “Board”), effective January 10, 2026.

GlobeNewsWire • 7 hours ago

Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R.

GlobeNewsWire • Jan 12, 2026

Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference

CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 3:00 p.m. PT (6:00 p.m. ET). During the presentation, Dan Scavilla, President and CEO of Dentsply Sirona, will provide an update on the Company's differentiated Connected Dentistry portfolio, dental market trends and the Company's progress against its return-to-growth strategy.

GlobeNewsWire • Jan 6, 2026

Dentsply Sirona Declares Quarterly Cash Dividend

CHARLOTTE, N.C., Dec. 15, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.

GlobeNewsWire • Dec 15, 2025

3 Healthcare Stocks Topping a 2025 List of Dividend Yields

Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its patent cliff issue.

The Motley Fool • Nov 13, 2025

New Strong Sell Stocks for Nov. 11

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Zacks Investment Research • Nov 11, 2025

Brickwood Asset Management Adds $19 Million in Dentsply Sirona (NASDAQ: XRAY) Shares: Should Investors Buy the Turnaround Stock?

Brickwood added 1,496,935 shares of XRAY, raising position value by $19.03 million. The transaction represented 15.2% of Brickwood's 13F reportable assets under management.

The Motley Fool • Nov 10, 2025

Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects

Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Zacks Investment Research • Nov 10, 2025

Dentsply Sirona Stock Sinks On Missed Expectations, Lowered 2025 Guidance; CEO Unveils Return-To-Growth Plan

Dentsply Sirona Inc. (NASDAQ:XRAY) stock is trading lower on Thursday after weaker-than-expected third-quarter earnings and lowered guidance.

Benzinga • Nov 6, 2025

DENTSPLY SIRONA Inc. (XRAY) Q3 2025 Earnings Call Transcript

DENTSPLY SIRONA Inc. ( XRAY ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Wade Moody Daniel Scavilla - President, CEO & Director Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division David Saxon - Needham & Company, LLC, Research Division Jordan Bernstein - Stifel, Nicolaus & Company, Incorporated, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Ahmed Muhammad Rahat - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Allen Lutz - BofA Securities, Research Division Brandon Vazquez - William Blair & Company L.L.C.

Seeking Alpha • Nov 6, 2025